EMA — authorised 9 January 2020
- Marketing authorisation holder: Instituto Grifols S.A.
- Status: approved
EMA authorised Tavalisse on 9 January 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 9 January 2020.
Instituto Grifols S.A. holds the EU marketing authorisation.